What does the evidence say about Lactoferrin Gut Health Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Lactoferrin Gut Health Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - While advances in perinatal medicine and neonatal intensive care have significantly improved the survival rates of preterm infants, this progress has been accompanied by a rise in the incidence of NEC, with a global prevalence of approximately 7.0% among infants with extremely low birth weight (ELBW). [Chen Siyi (2026); evidence level 3] - The precise etiology and pathogenesis of NEC remain incompletely understood; it is generally posited to be associated with multiple factors, such as intestinal barrier immaturity in preterm infants, gut microbiota dysbiosis, inappropriate feeding practices, and abnormal inflammatory responses (,). [Chen Siyi (2026); evidence level 3] - These antimicrobial proteins, together with HMOs, support the establishment of a healthy microbiota, crucial for reducing the risk of NEC. [Chen Siyi (2026); evidence level 3] - 1 2 3 4 5 6 Necrotizing enterocolitis (NEC) is a critical intestinal emergency that predominantly affects neonates, especially those born prematurely. [Chen Siyi (2026); evidence level 3] - As an integral component of the human diet, dairy products are rich in high-quality protein, lactoferrin, conjugated linoleic acid, calcium, vitamin D, and various other nutrients and bioactive compounds. [Wang M (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.